Skip to content

Clinical trials

Phase 2 Shock, Septic trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Shock, Septic Phase: Phase 2 Country / region: United States Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20042
20081
20091
20102
20133
20152
20161
20171
20185
20193
20201
20211
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Terminated5
Unknown status5
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca1
Beth Israel Deaconess Medical Center1
Brigham and Women's Hospital1
Carilion Clinic1
Community Medical Center, Toms River, NJ1
Dascena1
Eisai Inc.1
Ferring Pharmaceuticals1
GlaxoSmithKline1
Hernando Gomez1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Shock, Septic25
Sepsis12
Systemic Inflammatory Response Syndrome3
Acute Kidney Injury2
Infections2
Multiple Organ Failure2
Shock2
Burns1
Endotoxemia1
Hyperlactatemia1

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.